OPEN END TURBO LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME3HKY7

Market Closed - Bid/Ask 09:39:49 20/06/2024 pm IST After market 12:15:20 am
2.47 EUR +16.51% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO. 2.715 +9.92%
Current month+6.00%
1 month-15.87%
Date Price Change
20/24/20 2.47 +16.51%
19/24/19 2.12 -5.36%
18/24/18 2.24 +6.16%
17/24/17 2.11 -6.22%
14/24/14 2.25 +7.66%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 09:39 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME3HKY
ISINDE000ME3HKY7
Date issued 13/11/2023
Strike 210.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.98
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.15
Lowest since issue 1.39
Spread 0.03
Spread %1.13%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus